KDM-1104

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKDM-1104
Drug Alias Namesumatriptan (Kedem)KDM-1104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1d (5-HT1d) receptor agonistsSerotonin 1b (5-HT1b) receptor agonists
TargetsSerotonin 1d (5-HT1d) receptorSerotonin 1b (5-HT1b) receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKedem Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKedem Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A